Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Progyny Inc

PGNY ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Managed Healthcare ·

USA Mid Cap Analyst: BUY

Last Close

$26.28

▲ +1.51%

Market Cap $2.02B · Vol 373.36K

Key Metrics

P/E Ratio

28.56

FWD: 16.39

Market Cap

$2.02B

Mid Cap

Div Yield

N/A

EPS Growth

+99.42%

YoY

RSI (14)

21.42

Momentum

Beta

0.97

vs Market

52W High

$33.05

20.48% below

52W Low

$16.10

63.23% above

Volume

373.36K

Avg 499.49K

P/B

4.15

Price-to-book

ROE

12.48%

Return on equity

Free Float

98.03%

Public shares

Shariah Compliance8 STANDARDS

✗ Progyny Inc (PGNY) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does PGNY pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-6.48%

-18.79%

+14.91%

+27.02%

YTD

+2.34%

+16.54%

-32.30%

-43.03%

Financials & Valuation

TTM · Annual

Total Revenue	$1.29B
Net Income	$58.52M
Revenue Growth (YoY)	+5.30%
Gross Margin	23.63%
Operating Margin	7.05%
Net Profit Margin	4.54%
ROE	12.48%
ROA · ROIC	14.14% · 12.48%

P/E Ratio	28.56
Forward P/E (FY1)	16.39
PEG Ratio	2.74
P/S	1.79
P/B	4.15
P/FCF	12.03
EPS Growth	+99.42%
Outstanding Shares	76.73M

Technical Indicators

50-Day SMA	$29.06
200-Day SMA	$23.78
RSI (14)	21.42
Beta	0.97
52-Week High	$33.05
52-Week Low	$16.10

Volume Today	373.36K
Avg Daily Volume (30D)	499.49K
Relative Volume	0.75x
Volatility (10D)	46.86
Volatility (30D)	37.79
Free Float	98.03%

Analyst Consensus

BUY

Current Price $26.28

Mean Target $34.40

52W Low$16.10 52W High$33.05

Current

Target

$16.10 $33.05

Current Analyst target

+30.90% upside potential · 11 analysts

Identifiers

ExchangeNasdaq

FIGIBBG002H1K1K7

ISINUS74340E1038

CountryUnited States of America

Sub-IndustryManaged Healthcare (NEC)

Earnings DateNov 4, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

UNH UnitedHealth Group Inc +0.67% MOH Molina Healthcare Inc +3.27% SAUD3.SA Odontoprev SA +0.36% HAPV3.SA Hapvida Participacoes e Investimentos SA +4.99%

Company Profile

Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.